CVE-2026-15415 — Katalog CVE

csirt@kutim:~/threat-intel/cve/CVE-2026-15415

CVSS 5.5 · Medium EPSS 0,35%

Kerentanan Relative Path Traversal. Skor CVSS 3.1 5.5 (Medium) menurut CNA.

Deskripsi (NVD)

AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.

Rincian

Terbit di NVD: 17 Juli 2026
Terakhir diubah: 20 Juli 2026
Status NVD: Awaiting Analysis
CVSS 3.1: 5.5 (Medium), sumber CNA
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N · uraikan di kalkulator
Jenis kelemahan (CWE): CWE-23: Relative Path Traversal
EPSS (30 hari): 0,35% peluang dieksploitasi; lebih tinggi dari 27,1% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.